Search

Search results

211 results found

Morgan Sheng, M.D., Ph.D.

he/him
Person:
Morgan Sheng is a core institute member of the Broad Institute of MIT and Harvard, where he serves as co-director of the Broad’s Stanley Center for Psychiatric Research and Head of Stanley Center Therapeutics. email: msheng AT broadinstitute DOT org

Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.

Publication: Journal Article
Meilandt, William J, Hai Ngu, Alvin Gogineni, Guita Lalehzadeh, Seung-Hye Lee, Karpagam Srinivasan, Jose Imperio, et al. 2020. “Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer’s Mouse Model.”. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 40 (9): 1956-74.